A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats

Abstract

This event-driven design takes into the account the potentially sporadic spread of Marburg virus. The proposed trial design may be applicable for other pathogens against which effective vaccines are not yet available.